{"id":2154984,"date":"2026-09-21T00:00:00","date_gmt":"2026-09-20T21:00:00","guid":{"rendered":"https:\/\/analyse.optim.biz\/?p=2154984"},"modified":"2026-09-21T00:00:00","modified_gmt":"2026-09-20T21:00:00","slug":"consiliul-concurentei-a-autorizat-preluarea-a-18-farmacii-marcos-provit-de-catre-dr-max-srl","status":"publish","type":"post","link":"https:\/\/analyse.optim.biz\/?p=2154984","title":{"rendered":"Consiliul Concuren\u021bei a autorizat preluarea a 18 farmacii Marcos Provit de c\u0103tre Dr. Max SRL"},"content":{"rendered":"<p>[analyse_image type=&#8221;featured&#8221; src=&#8221;https:\/\/agerpres.ro\/data\/202609\/20260921134326_569336.jpg&#8221;]<\/p>\n<div class=\"mx-auto pt-3\">\n<p><strong>Consiliul Concuren\u021bei a autorizat tranzac\u021bia prin care Dr.Max SRL inten\u021bioneaz\u0103 s\u0103 preia controlul asupra activit\u0103\u021bii desf\u0103\u0219urate de 18 farmacii operate anterior de grupul Marcos Provit, conform unui comunicat al organiza\u021biei.<\/strong><\/p>\n<p>Dr.Max SRL este o societate activ\u0103 pe pia\u021ba comer\u021bului cu am\u0103nuntul de produse farmaceutice \u0219i parafarmaceutice. Dr.Max SRL face parte din grupul controlat de Penta Investments Limited, un grup de investi\u021bii specializat \u00een investi\u021bii pe termen lung. \u00cen Rom\u00e2nia, grupul Penta este activ, \u00een principal, \u00een sectorul farmaceutic \u0219i cel al jocurilor de noroc.<\/p>\n<p>Cele 18 farmacii achizi\u021bionate desf\u0103\u0219oar\u0103 activitate \u00een jude\u021bele Sibiu, Vrancea, Gala\u021bi, Bra\u0219ov \u0219i Ilfov.<\/p>\n<p>\u00cen urma analizei, Consiliul Concuren\u021bei a constatat c\u0103 aceast\u0103 opera\u021biune nu ridic\u0103 obstacole semnificative \u00een calea concuren\u021bei efective pe pia\u021ba rom\u00e2neasc\u0103 sau pe o parte substan\u021bial\u0103 a acesteia \u0219i c\u0103 nu exist\u0103 \u00eendoieli serioase privind compatibilitatea sa cu un mediu concuren\u021bial normal.<\/p>\n<p>Decizia va fi publicat\u0103 pe site-ul autorit\u0103\u021bii na\u021bionale de concuren\u021b\u0103, dup\u0103 eliminarea informa\u021biilor cu caracter confiden\u021bial. AGERPRES\/(AS &#8211; redactor: George B\u0103nciulea, editor: Mariana Nica, editor online: Ada V\u00eelceanu)<\/p>\n<\/div>\n<div class=\"mx-auto pt-3\">\n                                Afisari: 145\n                            <\/div>\n<p>[analyse_source url=&#8221;https:\/\/agerpres.ro\/economic\/2026\/09\/21\/consiliul-concurentei-a-autorizat-preluarea-a-18-farmacii-marcos-provit-de-catre-dr-max-srl&#8211;1595476&#8243;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[analyse_image type=&#8221;featured&#8221; src=&#8221;https:\/\/agerpres.ro\/data\/202609\/20260921134326_569336.jpg&#8221;] Consiliul Concuren\u021bei a autorizat tranzac\u021bia prin care Dr.Max SRL inten\u021bioneaz\u0103 s\u0103 preia controlul asupra activit\u0103\u021bii desf\u0103\u0219urate de 18 farmacii operate anterior de grupul Marcos Provit, conform unui comunicat al organiza\u021biei. Dr.Max SRL este o societate activ\u0103 pe pia\u021ba comer\u021bului cu am\u0103nuntul de produse farmaceutice \u0219i parafarmaceutice. Dr.Max SRL face parte din grupul [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[37,226],"class_list":["post-2154984","post","type-post","status-publish","format-standard","hentry","category-politics","tag-agerpres-ro","tag-crawlmanager"],"_links":{"self":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/2154984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2154984"}],"version-history":[{"count":0,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/2154984\/revisions"}],"wp:attachment":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2154984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2154984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2154984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}